2-(3-((3-Fluorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 100mg

2-Chloro-4-phenylpyrimidine, 95.0%, 5g

2-(Trifluoromethyl)nicotinonitrile, 97.0%, 5g

5-hydroxy-2-(4-morpholinylmethyl)-4H-pyran-4-one, 95.0%, 5g

2-Methyl-4-trifluoromethoxyphenylboronic acid pinacol ester, 250mg

Methyl 6-methoxy-5-methylpyridine-3-carboxylate, 98%, 250mg

1-(tert-Butyl) 2-ethyl (2S,4S)-4-aminopyrrolidine-1,2-dicarboxylate hydrochloride, 98%, 1g

Ethyl 2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)-3-nitrobenzoate, 98%, 100g

bicyclo[2.2.2]octan-1-amine, hydrochloride, 95.0%, 250mg

NARDOSINONE, 98%, 5mg

7-[5-[[4-[4-[(Dimethylamino)sulfonyl]-1-piperazinyl]phenoxy]methyl]-1,3-dimethyl-1H-pyrazol-4-yl]-1-[2-(4-morpholinyl)ethyl]-3-[3-(1-naphthalenyloxy)propyl]-1H-indole-2-carboxylic acid, 98%, 10mg

N-Hydroxysuccinimide, min. 99%, for synthesis, 25 g, glass packaging